Btw, June 24 will have BTX subsidiary ESI present GE product update.
GE/BTX partnership announced bacK in Dec, stem cell drug testing kits likely to be covered on June 24th presentation, if so expect nice move upwards.
Have doubled over last year, 4th quarter triple coming as PanC-DX to be released to market along with drug testing/GE kits and Renevia for reconstructive surgery in EU. Talking billions in revenue. BTX best kept secret, but not for long.
Bump...let's keep things in perspective. PanC-DX bladder and lung positive results, cancer diagnostic products on track for 4th Q release.
BioTime, Inc. (NYSE MKT: BTX) today announced that Chief Executive Officer Michael D. West, PhD will present at the Jefferies 2015 Global Healthcare Conference to be held in New York on June 1-4, 2015. Dr. West will provide an overview of the company and an update on product development in his presentation at 3:00 PM EDT on Wednesday, June 3, 2015.